Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?

Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?

Nature, Published online: 11 August 2020; doi:10.1038/d41586-020-02360-y

Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out.
Source: Nature